RPRX Volume Alert - RPRX 9.35 Repros Therapeutics Inc $RPRX

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:59 PM

RPRX Volume Alert - RPRX 9.35 Repros Therapeutics Inc $RPRX Hit a high of 9.65 Currently 11:15 Last price 9.35 -0.77 -7.61% With a day low of 8.55 and a current volume of 1,677,952.

RPRX Repros Therapeutics Inc Recent Headline News

Repros Therapeutics posts 3Q loss
Automated Insights - Mon Nov 10, 8:13AM CST
WOODLANDS, Texas (AP) _ Repros Therapeutics Inc. (RPRX) on Monday reported a loss of $7.4 million, or 32 cents per share, in its third quarter.
RPRX: 9.35 (-0.77)

Repros Therapeutics beats by $0.07
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:11AM CST

RPRX: 9.35 (-0.77)

Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 8:00AM CST
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2014.
RPRX: 9.35 (-0.77)

Nasdaq stocks posting largest percentage increases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SWIR: 35.64 (+1.74), PERI: 5.76 (+0.01), UNXL: 5.60 (+0.29), TREE: 47.40 (+0.37), SSRI: 4.77 (-0.43), STMP: 43.68 (+0.76), RPRX: 9.35 (-0.77), NYNY: 7.69 (-0.05), SHLD: 39.88 (-2.93), AREX: 10.38 (-0.35), PGNX: 5.86 (+0.49), ECYT: 6.13 (+0.10), SSO.TO: 5.44 (-0.46), SGMA: 7.27 (+0.06), SW.TO: 40.58 (+2.19), PLNR: 7.51 (+1.11)

Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.08 (+0.03), AMSC: 1.18 (+0.01), RPRX: 9.35 (-0.77), SHLD: 39.88 (-2.93), STAY: 18.41 (+0.11)

Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:52AM CST

ROKA: 3.47 (+0.47), NES: 8.56 (-0.72), FNGN: 31.05 (-0.34), FIVN: 4.91 (-0.17), MSON: 11.07 (-0.73), SLXP: 93.11 (+1.64), SUMR: 1.86 (-0.20), RPRX: 9.35 (-0.77), QTWO: 18.06 (-0.81), EV: 42.86 (-1.04), SHLD: 39.88 (-2.93), STAY: 18.41 (+0.11), PSIX: 68.40 (-0.75), BORN: 1.50 (+0.02), URRE: 2.47 (+0.53), ECOM: 18.28 (+0.43), ICPT: 175.00 (+2.41), SAEX: 4.50 (-0.42), VPCO: 1.80 (-0.14), SZYM: 3.61 (-0.02)

Repros Therapeutics (RPRX) Stock Skyrockets After Meeting with FDA About Androxal
at The Street - Fri Nov 07, 10:07AM CST
Shares of Repros Therapeutics (RPRX) soared in morning trading Friday after the biopharmaceutical company held what it called a "constructive meeting" with the FDA regarding its testosterone-boosting drug Androxal.
RPRX: 9.35 (-0.77)

Repros jumps after FDA meeting on Androxal NDA
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 9:20AM CST

RPRX: 9.35 (-0.77)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.43 (+0.03), ANET: 78.87 (+1.04), TKMR: 16.39 (-0.36), ORBC: 5.95 (+0.15), MDRX: 11.32 (-0.22), RMTI: 10.70 (+0.15), CTIC: 2.10 (-0.03), SHLD: 39.88 (-2.93), UBNT: 29.39 (+0.61), RIG: 29.28 (-0.43), KGC: 2.33 (-0.17), APT: 3.25 (-0.01), ANF: 28.50 (-1.00), MITK: 3.16 (+0.20), ZNGA: 2.47 (+0.04), CNET: 2.08 (-0.03), KING: 13.73 (+0.01), NETE: 1.44 (+0.02), SLXP: 93.11 (+1.64), RPRX: 9.35 (-0.77), NADL: 5.08 (-0.36), PGNX: 5.86 (+0.49), AVNR: 13.20 (+0.18), FSLR: 51.89 (+1.60), DVA: 74.55 (+0.06), NDLS: 24.57 (-0.25), ICPT: 175.00 (+2.41), AGIO: 80.28 (+8.22), PLNR: 7.51 (+1.11)

Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing
GlobeNewswire - Thu Nov 06, 3:21PM CST
-- No New Clinical Studies Requested
RPRX: 9.35 (-0.77)

Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:12PM CST
Repros Therapeutics Inc. (RPRX) has an earnings ESP of 0.00% and a Zacks Rank #4 (Sell).
MNK: 92.83 (+1.77), PBH: 31.40 (-1.39), RPRX: 9.35 (-0.77), HSP: 56.06 (-0.26)

63.7% Return Seen to Date on SmarTrend Repros Therapeutics Call (RPRX)
Comtex SmarTrend(R) - Mon Nov 03, 10:56AM CST
SmarTrend identified a Downtrend for Repros Therapeutics (NASDAQ:RPRX) on September 4th, 2014 at $17.86. In approximately 2 months, Repros Therapeutics has returned 63.72% as of today's recent price of $6.48.
RPRX: 9.35 (-0.77)

Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 5.95 (-0.09), PTX: 9.50 (+0.41), AKRX: 35.65 (-0.94), RPRX: 9.35 (-0.77), NKTR: 13.61 (+0.26)

Repros to Webcast Investor and Analyst Day on October 31st
GlobeNewswire - Mon Oct 27, 3:01PM CDT
Repros Therapeutics Inc.(Nasdaq:RPRX) today announced that it will host a live webcast of its Investor and Analyst Day that is being held in New York City on Friday, October 31, 2014 beginning at 7:30 a.m. Eastern Time.
RPRX: 9.36 (-0.76)

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 22, 10:18AM CDT
Will Amgen (AMGN) go the Abbott (ABT) way and split into two separate companies?
PCYC: 134.09 (+0.60), NPSP: 26.55 (-0.94), RPRX: 9.36 (-0.76), AMGN: 162.61 (+2.36), ABBV: 63.55 (+2.05), REGN: 384.88 (+7.04), CELG: 107.86 (+1.41)

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Repros Therapeutics Inc. - RPRX
PR Newswire - Mon Oct 20, 12:33PM CDT
Levi & Korsinsky, LLP is investigating Repros Therapeutics Inc. ("Repros" or the "Company"

(NasdaqCM: RPRX) in connection with possible violations of federal securities laws.
RPRX: 9.36 (-0.76)

INVESTOR ALERT: Investigation of Repros Therapeutics Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Mon Oct 20, 9:36AM CDT
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Repros Therapeutics Inc. ("Repros Therapeutics" or the "Company"

(NASDAQ: RPRX) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by the Company concerning the Company's business and financial prospects.
RPRX: 9.36 (-0.76)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PerfectVape Unveils Online Deals Amid Vape Craze

PerfectVape's Digital Bargain Bonanza Alright, so you think you've seen savings? Well, PerfectVape's throwing a real bone to those hunting for vape deals online. They're slapping 10% off on select disposable vapes—no strings, just a promo code, PV10, you punch in at checkout. We've got ourselves an internet-era sale without needing to elbow through crowds. Browsing Made...

McCann Systems Scores Big with Dual AV Awards Wins

Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....

Pentair Faces Class Action Over Fraud Allegations

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

NOVOSENSE's Bold Performance Amid Rapid IC Demand

Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...

University of Phoenix Boosts Networking Strategies

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...

Agroz: Awards Fuel Momentum in AgriTech Sphere

Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...

Project 777 Bolsters Leadership with AI and Space Experts

Fortifying Project 777 with Tech Titans You'd think bolstering a team THIS stacked would feel daunting to others in the AI race, but A2035 Ventures is just getting started. Their latest move? Bringing in Sean Perry from Meta's Agentic AI and Preston Dunlap, ex-CTO of the U.S. Space Force. These aren't your garden-variety hires; they signify a deliberate step into the next...

ACEMAGIC Unveils New AI Mini Workstation at IFA 2026

A Glimpse Into ACEMAGIC's Latest Innovation Look if you had told me five years ago that AI mini workstations would be making waves, I'd have probably smirked. Yet, here we are; ACEMAGIC is setting the stage at IFA 2026 in Berlin with their fresh-out-the-oven F9A AI mini workstation, powered by AMD's Ryzen AI Max+ PRO 495 processor. It all goes down from September 4 to 8...

Lennar Unveils Lake Martin Community Homes

Lake Martin's New Residential Offering Step aside, beaches and mountains. Now it's all about lakeside living with some good old Alabama charm. Lennar, a heavyweight in the homebuilding scene, is opening the gates to The Oaks at Eclectic—a fresh batch of single-family homes sprouting near Lake Martin in Eclectic, Alabama. This spot is practically a haven for those who...

Parents Champion Meta's Online Safety Agreement

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....